159 related articles for article (PubMed ID: 36016851)
21. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
Peng BH; Ji YF; Qiu XJ
J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression.
Zhang H; Wang X; Hu B; Zhang F; Wei H; Li L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3410-3416. PubMed ID: 31407591
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
[TBL] [Abstract][Full Text] [Related]
24. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
Zeng F; You S; Dai X
Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
26. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
Gao P; Wang Z; Hu Z; Jiao X; Yao Y
J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
[TBL] [Abstract][Full Text] [Related]
27. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
[TBL] [Abstract][Full Text] [Related]
28. Retracted: circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.
Markers D
Dis Markers; 2023; 2023():9757632. PubMed ID: 37564088
[TBL] [Abstract][Full Text] [Related]
29. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
PeerJ; 2023; 11():e16447. PubMed ID: 38084139
[TBL] [Abstract][Full Text] [Related]
30. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.
Zhang Q; Wang Y
Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577
[TBL] [Abstract][Full Text] [Related]
31. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Ma J; Qi G; Li L
Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
[TBL] [Abstract][Full Text] [Related]
32. Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer.
Li X; Zhang Z; Jiang H; Li Q; Wang R; Pan H; Niu Y; Liu F; Gu H; Fan X; Gao J
Cell Physiol Biochem; 2018; 51(5):2324-2340. PubMed ID: 30537738
[TBL] [Abstract][Full Text] [Related]
33. circHIPK3 Acts as Competing Endogenous RNA and Promotes Non-Small-Cell Lung Cancer Progression through the miR-107/BDNF Signaling Pathway.
Hong W; Zhang Y; Ding J; Yang Q; Xie H; Gao X
Biomed Res Int; 2020; 2020():6075902. PubMed ID: 33015172
[TBL] [Abstract][Full Text] [Related]
34. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
36. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.
Zhang H; Luo Z; Tang J; Tian J; Xiao Y; Sun C; Wang T
Cell Cycle; 2022 Jan; 21(1):63-73. PubMed ID: 34985387
[TBL] [Abstract][Full Text] [Related]
38. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
40. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration.
Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
